6MK.DE: Summary for MERCK CO. DL-,01 - Yahoo Finance

UK Markets closed

Merck & Co., Inc. (6MK.DE)


Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
58.66+1.59 (+2.79%)
As of 4:35PM CET. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close57.07
Open58.80
Bid58.38 x 100000
Ask58.46 x 100000
Day's range58.20 - 59.30
52-week range56.91 - 60.32
Volume2,472
Avg. volume1,879
Market capN/A
BetaN/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Barrons.com50 minutes ago

    Bristol-Myers Squibb: There Goes Any Chance for Upside

    Poor Bristol-Myers Squibb (BMY)--and poor anyone who had been bullish on its shares. It's even more on sale today, however, after Bristol-Myers said that it wouldn't seek accelerated approval of its lung-cancer treatment combination last night, with shares off 10% at $49.94 at 12:05 p.m. today. Credit Suisse analysts Vamil Divan and Barbara Kotei write that the news "removes the possibility for near-term BMY Upside": Bristol-Myers Squibb announced after the close that they have decided to not pursue an accelerated filing strategy for their Opdivo+Yervoy combination in 1st line metastatic/advanced non-small cell lung cancer (NSCLC).

  • Reuters - UK Focus56 minutes ago

    Bristol-Myers shares fall on lung cancer timeline setback

    Shares (Berlin: DI6.BE - news) of Bristol-Myers Squibb fell nearly 10 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug combination in first-line lung cancer, further solidifying Merck & Co (Swiss: MRK-USD.SW - news) 's leading position in the burgeoning immuno-oncolgy field. Lung cancer is by far the biggest oncology market and a handful of companies have been jockeying for position in the battle to become dominant in initial, or first-line, treatment, and to provide much-needed combination therapies. Merck (LSE: 0O14.L - news) shares rose 3.8 percent to $62.60, while Bristol fell to $50.04.

  • TheStreet.com1 hour ago

    Ready to Trade Bristol-Myers Squibb, Bank of America, CSX? Here's What to Know

    Here's how to trade seven of the most active stocks on the market this week.